1. Official Journal of European Union. Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits of foodstuffs of animal origin. Pub. L. No. 15/72 (January 20, 2010).
2. WedgewoodPetRx.com [Internet]. New Jersey (USA): Wedgewood Pharmacy; c2004-13 [cited 2014 May 04]. Available from: http://www.wedgewoodpetrx.com/
3. PetMD [Internet]. Pennsylvania (USA): Pet360, Inc.; c1999-2014 [cited 2014 May 04]. Available from: http://www.petmd.com/
4. Official Journal of European Communities. Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. Pub. L. No. 311/1-66 (November 28, 2001).
5. Official Journal of European Communities. Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 on the Community code relating to veterinary medicinal products. Pub. L. No. 136/58-84 (April 30, 2004).
6. Veterinary EU Legislation: Medicines [Internet]. Brussels (EU): Federation of Veterinarians of Europe (FVE); c2014 [cited 2014 May 07]. Available from: http://www.fve.org/veterinary/medicines.php#1
7. Veterinary medicines: regulatory information [Internet]. London (UK): European Medicines Agency; c1995-2014 [cited 2014 May 07]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl= pages/regulation/landing/veterinary_medicines_ regulatory.jsp&mid=
8. British Pharmacopoeia Commission. British Pharmacopoeia (Veterinary) 2012. Norwich: The Stationery Office; 2011.
9. China Veterinary Pharmacopoeia Commission. Veterinary Pharmacopoeia of the People’s Republic of China. 2010 ed. Beijing: China Agriculture Press; 2010.
10. Indian Pharmacopoeia 2014: Veterinary monographs. 7th ed. Raj Nagar, Ghaziabad: Indian Pharmacopoeia Commission; 2014.
11. European Pharmacopoeia. 7th ed. Strasbourg: European Directorate for the Quality of Medicines - Council of Europe; 2010-2012.
12. British Pharmacopoeia Commission. British Pharmacopoeia 2012. Norwich: The Stationery Office; 2011.
13. United States Pharmacopeia and National Formulary (USP 33-NF 28). Rockville: United States Pharmacopeia Convention; 2009.
14. Society of Japanese Pharmacopoeia. Japanese Pharmacopoeia. 16th ed. Tokyo: Maruzen Company, Ltd.; 2012.
15. The International Pharmacopoeia. 4th ed. Geneva: World Health Organization; 2006.
16. Product Monograph. Flagyl® (Metronidazole) 10% w/w Cream, 500 mg Capsules. Quebec: Sanofi- Aventis Canada Inc.; 2013.
17. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1), Current Step 4 version, Parent Guideline dated 27 October 1994 [cited 2014 Oct 07]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__ Guideline.pdf
18. Tashtoush, BM., Jacobson, EL., Jacobson, MK. (2008). Validation of a simple and rapid HPLC method for determination of metronidazole in dermatological formulations. Drug Dev Ind Pharm. 34(8): 840-844. http://dx.doi.org/10.1080/03639040801928598 PMid:18618307 [Crossref] [Web of Science]
19. Melikyan, AL., Martirosyan, SS., Grigoryan, SR., Topchyan, VH., Davtyan, KT. (2013). Development and validation of HPLC method for the determination of metronidazole benzoate and related impurities in bulk and pharmaceutical formulations. IJPSR. 4(7): 2594-2599.
About the article
Published Online: 2015-11-18
Published in Print: 2015-03-01
© 2015. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. (CC BY-NC-ND 4.0)